---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-001610"
form_type: "8-K"
ticker: "UG"
cik: "0000101295"
company_name: "UNITED GUARDIAN INC"
filed_at: "2025-03-21T23:59:59+00:00"
generated_at: "2026-05-24T07:53:05.581662+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# United-Guardian FY 2024 net sales +12% to $12.18M; EPS $0.71 vs $0.56

## Summary
- Net income $3.25M ($0.71 per share) vs $2.58M ($0.56) in FY 2023.
- Cosmetics ingredients sales surged 32%; medical lubricants up 16%.
- Pharmaceutical sales fell 5% due to Renacidin supply disruption into Q1 2024.
- Management expects Renacidin sales to recover to prior levels in 2025.
- Growth driven by increased demand from largest distributor and Chinese accounts.

## SEC filing metadata
- accession: 0001171843-25-001610
- form_type: 8-K
- ticker: UG
- cik: 0000101295
- company_name: UNITED GUARDIAN INC
- filed_at: 2025-03-21T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/101295/000117184325001610/0001171843-25-001610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/101295/000117184325001610/f8k_032025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-001610
- JSON: https://secwatch.observer/filing/0001171843-25-001610.json
- Plain text: https://secwatch.observer/filing/0001171843-25-001610.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.